Polar Asset Management Partners’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Polar Asset Management Partners’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-379,700	Closed	-$2.53M	–	953
2023 Q3	$2.53M	Buy	379,700 +142,400	+60%	+$1.18M	0.06%	349
2023 Q2	$2.15M	Hold	237,300	–	–	0.04%	447
2023 Q1	$1.73M	Hold	237,300	–	–	0.03%	522
2022 Q4	$1.73M	Sell	237,300 -113,600	-32%	-$843K	0.02%	642
2022 Q3	$2.71M	Buy	350,900 +147,900	+73%	+$1.26M	0.03%	644
2022 Q2	$1.38M	Buy	+203,000	New	+$1.55M	0.02%	729

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Polar Asset Management Partners's PNT Position: Q4 2023 in Review

Polar Asset Management Partners sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 379,700 shares — an estimated $2.53M sold.

Polar Asset Management Partners first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $2.71M in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Polar Asset Management Partners reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Polar Asset Management Partners sold 379,700 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $2.53M.
Polar Asset Management Partners first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Polar Asset Management Partners's POINT Biopharma Global Inc. Common Stock position peaked at $2.71M in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.